Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2047504370', 'doi': 'https://doi.org/10.1021/jm960558a', 'title': 'Potent, Selective, Orally Active 3-Oxo-1,4-benzodiazepine GPIIb/IIIa Integrin Antagonists', 'display_name': 'Potent, Selective, Orally Active 3-Oxo-1,4-benzodiazepine GPIIb/IIIa Integrin Antagonists', 'publication_year': 1996, 'publication_date': '1996-01-01', 'ids': {'openalex': 'https://openalex.org/W2047504370', 'doi': 'https://doi.org/10.1021/jm960558a', 'mag': '2047504370', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/8960544'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1021/jm960558a', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S162030435', 'display_name': 'Journal of Medicinal Chemistry', 'issn_l': '0022-2623', 'issn': ['0022-2623', '1520-4804'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320006', 'host_organization_name': 'American Chemical Society', 'host_organization_lineage': ['https://openalex.org/P4310320006'], 'host_organization_lineage_names': ['American Chemical Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5088660771', 'display_name': 'James M. Samanen', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'James M. Samanen', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5025603688', 'display_name': 'Fadia E. Ali', 'orcid': 'https://orcid.org/0000-0001-7708-7878'}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Fadia E. Ali', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5090104496', 'display_name': 'Linda S. Barton', 'orcid': 'https://orcid.org/0009-0006-2621-1457'}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Linda S. Barton', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5091006962', 'display_name': 'William E. Bondinell', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'William E. Bondinell', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5089889210', 'display_name': 'Joelle L. Burgess', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Joelle L. Burgess', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5046552259', 'display_name': 'James F. Callahan', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'James F. Callahan', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5054113829', 'display_name': 'Raul R. Calvo', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Raul R. Calvo', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5011010577', 'display_name': 'Runzhe Chen', 'orcid': 'https://orcid.org/0000-0003-3834-2156'}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Wenting Chen', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5042285386', 'display_name': 'Lichong Chen', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Lichong Chen', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5047823547', 'display_name': 'Karl F. Erhard', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Karl Erhard', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5003026401', 'display_name': 'Giora Feuerstein', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Giora Feuerstein', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5082118182', 'display_name': 'Richard Heys', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Richard Heys', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5041947462', 'display_name': 'Shing Mei Hwang', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Shing-Mei Hwang', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5082711140', 'display_name': 'Dalia R. Jakas', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Dalia R. Jakas', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5081970999', 'display_name': 'Richard M. Keenan', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Richard M. Keenan', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5023264227', 'display_name': 'Thomas W. Ku', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Thomas W. Ku', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5084417466', 'display_name': 'Chet Kwon', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Chet Kwon', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5077624639', 'display_name': 'Chao‐Pin Lee', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Chao-Pin Lee', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102945198', 'display_name': 'William H. Miller', 'orcid': 'https://orcid.org/0000-0002-4454-0987'}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'William H. Miller', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5012876245', 'display_name': 'Kenneth A. Newlander', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kenneth A. Newlander', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102889859', 'display_name': 'Andrew Nichols', 'orcid': 'https://orcid.org/0009-0005-4573-1151'}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Andrew Nichols', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5057318994', 'display_name': 'Michael F. Parker', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Michael Parker', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5006862248', 'display_name': 'Catherine E. Peishoff', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Catherine E. Peishoff', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5007677300', 'display_name': 'Gerald Rhodes', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Gerald Rhodes', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5068867910', 'display_name': 'Steven T. Ross', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Steven Ross', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5018092461', 'display_name': 'Arthur Y. L. Shu', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Arthur Shu', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5104229498', 'display_name': 'Richard J. Simpson', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Richard Simpson', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5065715881', 'display_name': 'Dennis T. Takata', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Dennis Takata', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5020638700', 'display_name': 'Tobias O. Yellin', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Tobias O. Yellin', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5017124339', 'display_name': 'Irene Uzsinskas', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Irene Uzsinskas', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5049477408', 'display_name': 'Joseph W. Venslavsky', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Joseph W. Venslavsky', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5043301225', 'display_name': 'Chuan-Kui Yuan', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Chuan-Kui Yuan', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5025206889', 'display_name': 'William F. Huffman', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086173', 'display_name': 'New Frontier', 'ror': 'https://ror.org/00qc61c04', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210086173']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'William F. Huffman', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, Radiochemistry Department, Department of Cellular Biochemistry, Pharmaceutical Sciences, Pharmacology Department, Department of Physical/Structural Chemistry, and Department of Pharmacokinetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406', 'institution_ids': ['https://openalex.org/I4210086173']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 1.641, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 71, 'citation_normalized_percentile': {'value': 0.869447, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 94, 'max': 95}, 'biblio': {'volume': '39', 'issue': '25', 'first_page': '4867', 'last_page': '4870'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10831', 'display_name': 'Integrin Signaling in Inflammation and Cancer', 'score': 0.9983, 'subfield': {'id': 'https://openalex.org/subfields/2723', 'display_name': 'Immunology and Allergy'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10831', 'display_name': 'Integrin Signaling in Inflammation and Cancer', 'score': 0.9983, 'subfield': {'id': 'https://openalex.org/subfields/2723', 'display_name': 'Immunology and Allergy'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10602', 'display_name': 'Glycosylation in Health and Disease', 'score': 0.9968, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10746', 'display_name': 'Platelet Disorders and Thrombosis Mechanisms', 'score': 0.9937, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/integrins', 'display_name': 'Integrins', 'score': 0.500577}], 'concepts': [{'id': 'https://openalex.org/C2778805511', 'wikidata': 'https://www.wikidata.org/wiki/Q1713', 'display_name': 'Citation', 'level': 2, 'score': 0.50658596}, {'id': 'https://openalex.org/C161191863', 'wikidata': 'https://www.wikidata.org/wiki/Q199655', 'display_name': 'Library science', 'level': 1, 'score': 0.46911624}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.38177922}, {'id': 'https://openalex.org/C74916050', 'wikidata': 'https://www.wikidata.org/wiki/Q841090', 'display_name': 'Classics', 'level': 1, 'score': 0.34693468}, {'id': 'https://openalex.org/C142362112', 'wikidata': 'https://www.wikidata.org/wiki/Q735', 'display_name': 'Art', 'level': 0, 'score': 0.2660579}, {'id': 'https://openalex.org/C41008148', 'wikidata': 'https://www.wikidata.org/wiki/Q21198', 'display_name': 'Computer science', 'level': 0, 'score': 0.23819822}], 'mesh': [{'descriptor_ui': 'D001570', 'descriptor_name': 'Benzodiazepinones', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D019039', 'descriptor_name': 'Platelet Glycoprotein GPIIb-IIIa Complex', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D000284', 'descriptor_name': 'Administration, Oral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001570', 'descriptor_name': 'Benzodiazepinones', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D001570', 'descriptor_name': 'Benzodiazepinones', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D001570', 'descriptor_name': 'Benzodiazepinones', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019039', 'descriptor_name': 'Platelet Glycoprotein GPIIb-IIIa Complex', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1021/jm960558a', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S162030435', 'display_name': 'Journal of Medicinal Chemistry', 'issn_l': '0022-2623', 'issn': ['0022-2623', '1520-4804'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320006', 'host_organization_name': 'American Chemical Society', 'host_organization_lineage': ['https://openalex.org/P4310320006'], 'host_organization_lineage_names': ['American Chemical Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/8960544', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 10, 'referenced_works': ['https://openalex.org/W110197148', 'https://openalex.org/W1990109135', 'https://openalex.org/W1993638185', 'https://openalex.org/W2004573425', 'https://openalex.org/W2026846490', 'https://openalex.org/W2037156600', 'https://openalex.org/W2039044366', 'https://openalex.org/W2062912306', 'https://openalex.org/W2065388595', 'https://openalex.org/W2090255358'], 'related_works': ['https://openalex.org/W657579294', 'https://openalex.org/W4387497383', 'https://openalex.org/W2948807893', 'https://openalex.org/W2778153218', 'https://openalex.org/W2748952813', 'https://openalex.org/W2527526854', 'https://openalex.org/W2078814861', 'https://openalex.org/W1986764834', 'https://openalex.org/W1976181487', 'https://openalex.org/W1531601525'], 'abstract_inverted_index': {'ADVERTISEMENT': [0], 'RETURN': [1], 'TO': [2], 'ISSUELetterNEXTPotent,': [3], 'Selective,': [4], 'Orally': [5], 'Active': [6], '3-Oxo-1,4-benzodiazepine': [7], 'GPIIb/IIIa': [8], 'Integrin': [9], 'AntagonistsJames': [10], 'M.': [11, 47], 'Samanen,': [12], 'Fadia': [13], 'E.': [14, 20, 67], 'Ali,': [15], 'Linda': [16], 'S.': [17], 'Barton,': [18], 'William': [19, 56, 90], 'Bondinell,': [21], 'Joelle': [22], 'L.': [23], 'Burgess,': [24], 'James': [25], 'F.': [26, 91], 'Callahan,': [27], 'Raul': [28], 'R.': [29, 44], 'Calvo,': [30], 'Wenting': [31], 'Chen,': [32, 34], 'Lichong': [33], 'Karl': [35], 'Erhard,': [36], 'Giora': [37], 'Feuerstein,': [38], 'Richard': [39, 46, 75], 'Heys,': [40], 'Shing-Mei': [41], 'Hwang,': [42], 'Dalia': [43], 'Jakas,': [45], 'Keenan,': [48], 'Thomas': [49], 'W.': [50, 85], 'Ku,': [51], 'Chet': [52], 'Kwon,': [53], 'Chao-Pin': [54], 'Lee,': [55], 'H.': [57], 'Miller,': [58], 'Kenneth': [59], 'A.': [60], 'Newlander,': [61], 'Andrew': [62], 'Nichols,': [63], 'Michael': [64], 'Parker,': [65], 'Catherine': [66], 'Peishoff,': [68], 'Gerald': [69], 'Rhodes,': [70], 'Steven': [71], 'Ross,': [72], 'Arthur': [73], 'Shu,': [74], 'Simpson,': [76], 'Dennis': [77], 'Takata,': [78], 'Tobias': [79], 'O.': [80], 'Yellin,': [81], 'Irene': [82], 'Uzsinskas,': [83], 'Joseph': [84], 'Venslavsky,': [86], 'Chuan-Kui': [87], 'Yuan,': [88], 'and': [89, 113, 175, 180, 209, 253, 270, 286, 288, 304], 'HuffmanView': [92], 'Author': [93], 'Information': [94, 300, 302], 'Department': [95, 101, 109, 114], 'of': [96, 102, 110, 115, 121, 165, 200, 226], 'Medicinal': [97], 'Chemistry,': [98, 112], 'Radiochemistry': [99], 'Department,': [100, 108], 'Cellular': [103], 'Biochemistry,': [104], 'Pharmaceutical': [105], 'Sciences,': [106], 'Pharmacology': [107], 'Physical/Structural': [111], 'Pharmacokinetics,': [116], 'SmithKline': [117], 'Beecham': [118], 'Pharmaceuticals,': [119], 'King': [120], 'Prussia,': [122], 'Pennsylvania': [123], '19406Cite': [124], 'this:': [125], 'J.': [126], 'Med.': [127], 'Chem.': [128], '1996,': [129], '39,': [130], '25,': [131], '4867–4870Publication': [132], 'Date': [133], '(Web):December': [134], '6,': [135], '1996Publication': [136], 'History': [137], 'Received29': [138], 'July': [139], '1996Published': [140, 143], 'online6': [141], 'December': [142], 'inissue': [144], '1': [145], 'January': [146], '1996https://pubs.acs.org/doi/10.1021/jm960558ahttps://doi.org/10.1021/jm960558arapid-communicationACS': [147], 'PublicationsCopyright': [148], '©': [149], '1996': [150], 'American': [151], 'Chemical': [152], 'SocietyRequest': [153], 'reuse': [154], 'permissionsArticle': [155], 'Views431Altmetric-Citations61LEARN': [156], 'ABOUT': [157], 'THESE': [158], 'METRICSArticle': [159], 'Views': [160], 'are': [161, 184, 197], 'the': [162, 193, 198, 227, 238, 251, 254, 259, 266, 272], 'COUNTER-compliant': [163], 'sum': [164], 'full': [166], 'text': [167], 'article': [168, 232], 'downloads': [169], 'since': [170], 'November': [171], '2008': [172], '(both': [173], 'PDF': [174], 'HTML)': [176], 'across': [177], 'all': [178], 'institutions': [179], 'individuals.': [181], 'These': [182], 'metrics': [183], 'regularly': [185], 'updated': [186, 210], 'to': [187, 192], 'reflect': [188], 'usage': [189], 'leading': [190], 'up': [191], 'last': [194], 'few': [195], 'days.Citations': [196], 'number': [199], 'other': [201], 'articles': [202], 'citing': [203], 'this': [204], 'article,': [205], 'calculated': [206], 'by': [207], 'Crossref': [208, 216], 'daily.': [211], 'Find': [212, 262], 'more': [213, 263], 'information': [214, 264], 'about': [215, 250], 'citation': [217], 'counts.The': [218], 'Altmetric': [219, 267], 'Attention': [220, 268], 'Score': [221, 269], 'is': [222, 274], 'a': [223, 230, 243], 'quantitative': [224], 'measure': [225], 'attention': [228], 'that': [229], 'research': [231], 'has': [233], 'received': [234], 'online.': [235], 'Clicking': [236], 'on': [237, 265], 'donut': [239], 'icon': [240], 'will': [241], 'load': [242], 'page': [244], 'at': [245], 'altmetric.com': [246], 'with': [247, 282], 'additional': [248], 'details': [249], 'score': [252, 273], 'social': [255], 'media': [256], 'presence': [257], 'for': [258], 'given': [260], 'article.': [261], 'how': [271], 'calculated.': [275], 'Share': [276, 291], 'Add': [277], 'toView': [278], 'InAdd': [279], 'Full': [280], 'Text': [281], 'ReferenceAdd': [283], 'Description': [284], 'ExportRISCitationCitation': [285], 'abstractCitation': [287], 'referencesMore': [289], 'Options': [290], 'onFacebookTwitterWechatLinked': [292], 'InRedditEmail': [293], 'Other': [294], 'access': [295], 'optionsGet': [296], 'e-AlertscloseSupporting': [297], 'Info': [298], '(1)»Supporting': [299], 'Supporting': [301], 'SUBJECTS:Aggregation,Antagonists,Cells,Peptides': [303], 'proteins,Receptors': [305], 'Get': [306], 'e-Alerts': [307]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2047504370', 'counts_by_year': [{'year': 2021, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 1}, {'year': 2018, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 2}, {'year': 2015, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 2}, {'year': 2013, 'cited_by_count': 2}, {'year': 2012, 'cited_by_count': 5}], 'updated_date': '2024-09-19T01:13:29.976486', 'created_date': '2016-06-24'}